West of Mpls MN about 50 miles on Hwy 12 | Maybe.
https://www.businesswire.com/news/home/20210315005197/en
UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours
Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo
Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant
No adverse events were recorded in the group
Submission for Emergency Use in the UK and Canada for the treatment and prevention of COVID-19 is planned immediately
SaNOtize is applying to regulatory authorities in the UK and Canada for Emergency Use authorization. Swift approval and ramp-up of manufacturing could facilitate an almost immediate safe return to work, school and society, and spur an economic recovery that is months – if not years – ahead of full global vaccination.
About SaNOtize
SaNOtize Research & Development Corp. is a biotech company based in Vancouver, BC working to commercialize the multi-faceted antimicrobial properties of a liquid producing nitric oxide. The company has developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections.
About Dr Stephen Winchester MSc MB BS FRCPath
Dr. Winchester is Consultant Medical Virologist at Frimley Health NHS Foundation Trust. Affiliated with Berkshire and Surrey Pathology Services (BSPS). BSPS is a joint contractual venture between Ashford and St Peter's Hospitals NHS Foundation Trust, Frimley Health NHS Foundation Trust, Royal Berkshire NHS Foundation Trust and Royal Surrey County Hospital NHS Foundation Trust.
About Robert Wilson
Robert Wilson is a former government Minister and Member of Parliament for the United Kingdom.
https://nocamels.com/2021/03/sanotize-production-israel-anti-covid-n...
SaNOtize Begins Production Of Anti-COVID Nasal Spray In Israel
SaNOtize, the company behind a proposed antiviral nasal spray for use against COVID-19 has started a production line in Israel where the Health Ministry gave interim approval for the sale of the product to people over 12 years of age, the Times of Israel reported this week. The company is also registered to begin sales in New Zealand.
SaNOtize has developed a number of nitric oxide-based therapies to treat a variety of bacterial, fungal, and viral diseases.
It was previously granted US and EU patents on its Nitric Oxide Releasing Solution (NORS) and is testing ready-to-use applications delivered through gargle solutions, nasal spray, and nasal lavage. Separate trials have shown that the solution was effective in lab conditions against viruses such as influenza A, hCoV-OC43 and H1N1 (swine flu), the company has said.
Time, and more testing will tell if this patented nitric oxide nasal spray that was tested is effective in treating covid-19, or if it's just snake oil.
|
Nasal spray for covid
